Duopharma Biotech

Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) is a leading Malaysian pharmaceutical company operating prominently within the healthcare, biotechnology, and consumer wellness sectors. The business focuses on the research, development, manufacturing, and commercialization of generic drugs, biosimilars, and over-the-counter (OTC) health products. Its core operations encompass an extensive portfolio of over 300 generic medicines and well-recognized consumer brands such as Champs, Flavettes, Proviton, and Uphamol. The company also specializes in high-value therapeutic areas including oncology, diabetes care, and renal care.

Duopharma Biotech is public listed, with a valuation of -.

Alternatives.pe lists Duopharma Biotech's financials, valuation trends, ownership structure and transaction activity.

You're on a preview of a profileGet a free trial to view it in full

Last Updated: 2026-08-18

You're on a preview of a profileGet a free trial to view it in full

Last Updated: 2026-08-18

Loading, please wait...

All information here may not be reproduced without explicit written permission from Alternatives.pe.

Glossary

Duopharma Biotech

Duopharma Biotech

Documents

Related News